Effectiveness and Treatment Persistence of Vedolizumab Compared to Anti‐Tumour Necrosis Factor‐α in Patients With Crohn's Disease: A Systematic Literature Review and Meta‐Analysis
Effectiveness and Treatment Persistence of Vedolizumab Compared to Anti‐Tumour Necrosis Factor‐α in Patients With Crohn's Disease: A Systematic Literature Review and Meta‐Analysis is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Effectiveness and Treatment Persistence of Vedolizumab Compared to Anti‐Tumour Necrosis Factor‐α in Patients With Crohn's Disease: A Systematic Literature Review and Meta‐Analysis have?
Effectiveness and Treatment Persistence of Vedolizumab Compared to Anti‐Tumour Necrosis Factor‐α in Patients With Crohn's Disease: A Systematic Literature Review and Meta‐Analysis has 10 citations in the OpenAlex counts ScholarIQ stores.
When was Effectiveness and Treatment Persistence of Vedolizumab Compared to Anti‐Tumour Necrosis Factor‐α in Patients With Crohn's Disease: A Systematic Literature Review and Meta‐Analysis published?
Effectiveness and Treatment Persistence of Vedolizumab Compared to Anti‐Tumour Necrosis Factor‐α in Patients With Crohn's Disease: A Systematic Literature Review and Meta‐Analysis has 2024 year in the ScholarIQ index.
What is the open-access status of Effectiveness and Treatment Persistence of Vedolizumab Compared to Anti‐Tumour Necrosis Factor‐α in Patients With Crohn's Disease: A Systematic Literature Review and Meta‐Analysis?
Effectiveness and Treatment Persistence of Vedolizumab Compared to Anti‐Tumour Necrosis Factor‐α in Patients With Crohn's Disease: A Systematic Literature Review and Meta‐Analysis has hybrid oa status in the ScholarIQ index.
What is the DOI of Effectiveness and Treatment Persistence of Vedolizumab Compared to Anti‐Tumour Necrosis Factor‐α in Patients With Crohn's Disease: A Systematic Literature Review and Meta‐Analysis?
The DOI for Effectiveness and Treatment Persistence of Vedolizumab Compared to Anti‐Tumour Necrosis Factor‐α in Patients With Crohn's Disease: A Systematic Literature Review and Meta‐Analysis is on the source record.
What is the PMID of Effectiveness and Treatment Persistence of Vedolizumab Compared to Anti‐Tumour Necrosis Factor‐α in Patients With Crohn's Disease: A Systematic Literature Review and Meta‐Analysis?
The PMID for Effectiveness and Treatment Persistence of Vedolizumab Compared to Anti‐Tumour Necrosis Factor‐α in Patients With Crohn's Disease: A Systematic Literature Review and Meta‐Analysis is on the source record.
What is the OpenAlex record for Effectiveness and Treatment Persistence of Vedolizumab Compared to Anti‐Tumour Necrosis Factor‐α in Patients With Crohn's Disease: A Systematic Literature Review and Meta‐Analysis?
The OpenAlex for Effectiveness and Treatment Persistence of Vedolizumab Compared to Anti‐Tumour Necrosis Factor‐α in Patients With Crohn's Disease: A Systematic Literature Review and Meta‐Analysis is on the source record.